跳至主要内容
临床试验/IRCT2016092229914N1
IRCT2016092229914N1已完成2 期

Zero-balance ultrafiltration method to evaluate the effect on clinical outcomes in patients undergoing coronary artery bypass surgery

Vice CHancellor For Research, Iran university Of Medical Sciences0 个研究点目标入组 75 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Non-inclusion criteria
  • Liver failure as ((AST> 40 unit / L) and (ALT> 40 unit / L);A history of heart surgery;High serum creatinine1/5mg / dL; And patients who received the drug because before during 5 days acute renal failure have had severe narrowing of the carotid both carotid or one of them; Surgery emergency; IE; Ejection fraction of the left ventricle less than 30 percent of patients with Severe failure right ventricle Hemoglobin less than 10;Mass index BMI greater than 40;Benign and malignant cancers;Clamped aortic bypass for more than 120 minutes and 150 minutes; Pulmonary function test abnormal preoperative FEV1 <65
  • Exclusion criteria
  • Prime 8/5000
  • Autologus do the opposite; Using the CUF; Using MUF; Patient died during surgery; Use of Intraoperative balloon pump;Use of ECMO; The need to stay open sternum after surgery; The patient needs cardiopulmonary resuscitation

排除标准

  • 未提供

研究者

发起方
Vice CHancellor For Research, Iran university Of Medical Sciences

相似试验